首页> 外文OA文献 >Developmental regulation of galactoglycerolipid and galactosphingolipid sulphation during mammalian spermatogenesis. Evidence for a substrate-selective inhibitor of testicular sulphotransferase activity in the rat.
【2h】

Developmental regulation of galactoglycerolipid and galactosphingolipid sulphation during mammalian spermatogenesis. Evidence for a substrate-selective inhibitor of testicular sulphotransferase activity in the rat.

机译:哺乳动物精子发生过程中半乳糖甘油脂和半乳糖鞘脂硫酸盐的发育调控。在大鼠睾丸磺基转移酶活性的底物选择性抑制剂的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The synthesis of sulphatoxygalactosylacylalkylglycerol (SGG) is a differentiation marker of mammalian spermatogenesis. Maximal sulphation is observed in rat testis at about 20 days after birth and rapidly declines to low levels as the testis matures. The present data show that this decline in SGG synthesis is due to the appearance of an inhibitor of galactolipid sulphation. The inhibitor is a soluble testicular factor which is first detected at about 25 days after birth. Testicular homogenate can sulphate exogenous galactosylacylalkylglycerol (GG), galactosylceramide (GC) and lactosylceramide (LC) in vitro. The testicular inhibitor is most effective in preventing GG sulphation and inhibits GC and LC sulphation to a lesser extent; this correlates with the finding that glycolipid sulphation shifts from SGG production in 20-day-old testis to GC and LC sulphation at later stages of testicular development. The effect of the inhibitor on sulphotransferase activity from brain and kidney was also determined. The inhibitor decreased the sulphation of GG in vitro by both testis and kidney, inhibited testicular sulphation of GC less effectively and had no effect on GC sulphation by kidney and brain homogenates. A 9500-fold purification of the inhibitory activity has been obtained in a fraction isolated by h.p.l.c.
机译:磺酰氧基半乳糖基糖基烷基甘油(SGG)的合成是哺乳动物精子发生的分化标记。在大鼠睾丸出生后约20天观察到最大程度的硫酸化,并随着睾丸的成熟而迅速下降至低水平。目前的数据表明,SGG合成的这种下降是由于半乳糖脂硫酸化抑制剂的出现。该抑制剂是可溶性​​睾丸因子,其在出生后约25天时首次被检测到。睾丸匀浆可以在体外硫酸化外源性半乳糖基糖基烷基甘油(GG),半乳糖基神经酰胺(GC)和乳糖基神经酰胺(LC)。睾丸抑制剂在预防GG硫酸盐化方面最有效,并在较小程度上抑制GC和LC硫酸盐化。这与糖脂硫酸化从20天大的睾丸中的SGG产生转变为睾丸发育后期的GC和LC硫酸化的发现有关。还确定了该抑制剂对来自脑和肾的磺基转移酶活性的影响。该抑制剂降低了睾丸和肾脏在体外对GG的硫酸化作用,降低了对GC的睾丸硫酸化的抑制作用,并且对肾脏和脑匀浆对GC的硫酸化没有影响。在通过h.p.l.c.分离的级分中获得了抑制活性的9500倍纯化。

著录项

  • 作者

    Lingwood, C A;

  • 作者单位
  • 年度 1985
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号